UNICA IRIS Institutional Research Information System

MANTOVANI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 34.074
NA - Nord America 3.927
AS - Asia 1.656
SA - Sud America 187
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 30
OC - Oceania 1
Totale 39.988
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 33.105
US - Stati Uniti d'America 3.843
CN - Cina 637
SG - Singapore 591
UA - Ucraina 275
SE - Svezia 200
BR - Brasile 142
VN - Vietnam 118
GB - Regno Unito 113
DE - Germania 104
FI - Finlandia 101
FR - Francia 86
HK - Hong Kong 74
KR - Corea 59
CA - Canada 57
IN - India 55
BD - Bangladesh 19
BE - Belgio 16
IQ - Iraq 15
ES - Italia 13
JP - Giappone 13
RU - Federazione Russa 13
AR - Argentina 11
PK - Pakistan 11
ZA - Sudafrica 11
MX - Messico 10
NL - Olanda 10
PL - Polonia 10
TR - Turchia 10
PH - Filippine 9
IR - Iran 8
JM - Giamaica 8
CL - Cile 7
CR - Costa Rica 5
EC - Ecuador 5
PY - Paraguay 5
AT - Austria 4
CO - Colombia 4
LT - Lituania 4
MY - Malesia 4
PE - Perù 4
UZ - Uzbekistan 4
VE - Venezuela 4
AL - Albania 3
BO - Bolivia 3
CG - Congo 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
ID - Indonesia 2
IE - Irlanda 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 39.875
Salva come PNG Salva come JPEG
Città #
Cagliari 32.041
Uta 856
Fairfield 406
Ashburn 348
Singapore 323
Woodbridge 265
Chandler 230
San Jose 226
Houston 204
Seattle 191
Nyköping 179
Boardman 158
Wilmington 153
Jacksonville 152
Cambridge 151
Ann Arbor 149
Dallas 149
Beijing 119
Los Angeles 72
Santa Clara 68
Dearborn 64
Hong Kong 64
Shanghai 53
Helsinki 51
Ho Chi Minh City 51
Seoul 51
Boston 49
Council Bluffs 49
Nanjing 49
Lauterbourg 48
New York 44
Guangzhou 36
Hefei 34
Buffalo 31
London 28
Hanoi 24
Changsha 22
The Dalles 22
Toronto 22
Pune 21
San Diego 21
Shenyang 18
Milan 17
Brussels 16
Munich 15
Rome 15
Tianjin 15
Chicago 12
Nanchang 12
Jiaxing 11
Redondo Beach 11
Jinan 9
Montreal 9
Redwood City 9
Atlanta 8
Baghdad 8
Norwalk 8
Tokyo 8
Kingston 7
Orange 7
San Mateo 7
São Paulo 7
Ankara 6
Auburn Hills 6
Belo Horizonte 6
Chennai 6
Hangzhou 6
Kunming 6
Orem 6
Phoenix 6
Turku 6
Verona 6
Warsaw 6
Barcelona 5
Brandizzo 5
Brooklyn 5
Columbus 5
Denver 5
Hebei 5
Poplar 5
Rio de Janeiro 5
San Francisco 5
Shenzhen 5
Stockholm 5
Wuhan 5
Augusta 4
Chongqing 4
Colombo 4
Curitiba 4
Detroit 4
Frankfurt am Main 4
Haiphong 4
Kilburn 4
Mexico City 4
Mountain View 4
Mumbai 4
Sassari 4
Somma Vesuviana 4
Torino 4
Valencia 4
Totale 37.689
Salva come PNG Salva come JPEG
Nome #
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.586
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.201
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 2.063
Advances in pharmacologic strategies for cancer cachexia 1.907
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.795
The nutritional risk in oncology: a study of 1,453 cancer outpatients 1.734
Randomised phase III clinical trial of 5 different arms of treatment for patients with cancer-related anorexia/cachexia syndrome (CACS) 1.514
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer 972
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 966
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 946
null 936
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial 920
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer 894
null 819
Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters 819
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapy 785
Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer 757
Current medications for cancer cachexia 740
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2 705
null 681
Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy 632
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: An evaluation of effectiveness, safety and costs 617
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes 593
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma 562
A phase II study with antioxidants, both in the diet an supplemented, pharmaco-nutritional support, progestagen and anti-COX-2 showing efficacy and safety in patients with cancer-related anorexia-cachexia and oxidative stress 536
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation 533
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate 532
null 529
Efficacy, compliance and prognostic significance of a comprehensive geriatric assessment in the geriatric cancer patient = Efficacia, applicabilità e significato prognostico di una valutazione geriatrica multidimensionale nel paziente oncologico anziano 522
Role of proinflammatory cytokines and leptin in cancer-related anorexia/cachexia. Metabolic abnormalities and therapeutic approaches = Ruolo delle citochine infiammatorie e della leptina nell'anoressia/cachessia neoplastica. Aspetti metabolici e terapeutici 520
Medroxyprogesterone acetate reduces the In vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 512
Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients 508
Cisplatin induces serotonin release from human peripheral blood mononuclear cells of cancer patients and methylprednisolone inhibits this effect 508
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation 495
Medroxyprogesterone acetate and megestrol acetate reduce cisplatin-induced serotonin release from human peripheral blood mononuclear cells of cancer patients 486
Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer: A tentative quantitative evaluation of organ preservation and clinical response 485
Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC 473
Tumor-associated lymphomonocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokynes 462
Relationships betxween Fas expression, activation molecule CD25, and functional activity of tumor-associated lymphomonocytes from neoplastic effusions 462
Medroxyprogesterone acetate reduces the production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients 461
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma: Larynx preservation and clinical response 431
Anorexia/Cachexia and oxidative stress in cancer patients = Anoressia/Cachessia e stress ossidativo nei pazienti con cancro 410
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG) 372
An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: Background and design of an ongoing, phase III, randomized clinical trial 333
Peripheral blood lymphocyte response to exogenous interleukin 2 by PHA-prestimulated and non-PHA-prestimulated cells in patients with cancer 330
Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies 288
[p55 and p75 subunits of the IL 2 receptor, membrane bound and soluble, in peripheral lymphocytes in patients with solid tumors] 257
Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1α, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies 182
Comparison of oral 5-HT3-receptor antagonists and low-dose oral metoclopramide plus i.m. dexamethasone for the prevention of delayed emesis in head and neck cancer patients receiving high-dose cisplatin 152
Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy 152
Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial 152
Lack of correlation between defective cell-mediated immunity and levels of secreted or circulating cytokines in a study of 90 cancer patients 137
Immunologic assessment determined by response to IL-2 and immunophenotyping of tumor-infiltrating lymphocytes, of invaded and non invaded lymph nodes and of peripheral blood lymphocytes from twenty-one patients with primary laryngeal cancer 136
Preovulatory human follicular fluid in vitro inhibits interleukin (IL)- 1α, IL-2, and production and expression of p55 chain IL-2 receptor of lymphomonocytes 127
Study of peripheral blood lymphocyte subset distribution and IL-2 receptor (IL-2 R) p55-p75 subunit expression in patients with cancer of different sites 123
[The immunological assessment of a combined therapeutic approach (chemo- + radiotherapy +/- surgery) including immunotherapy in neoplasms of the head and neck area at an advanced stage] 115
Evidence that granulosa cells inhibit interleukin-1α and interleukin-2 production from follicular lymphomonocytes 86
Medical imaging: a segmentation algorithm 37
Totale 39.988
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.235 0 104 90 69 154 83 60 91 118 102 158 206
2022/20232.436 185 235 180 175 175 290 71 461 164 146 211 143
2023/20243.628 245 128 131 271 356 660 389 235 196 352 304 361
2024/20254.739 389 796 834 760 493 783 278 55 91 73 102 85
2025/20262.558 161 128 330 225 253 157 455 111 211 325 141 61
2026/2027189 32 157 0 0 0 0 0 0 0 0 0 0
Totale 39.988